Historical Stock Price
ETFs Holding EXAS »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
06/27/2022 $45.23 $45.28 $42.52 $44.10 1.63M
06/28/2022 $44.00 $44.91 $40.95 $41.11 2.26M
06/29/2022 $40.83 $41.36 $39.61 $40.58 1.19M
06/30/2022 $40.13 $40.42 $38.53 $39.39 1.75M
07/01/2022 $39.81 $41.51 $39.61 $41.13 1.46M
Exact Sciences is a cancer screening and diagnostics company. Co.'s primary screening product, the Cologuard® test, is a non-invasive stool-based DNA screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Co.'s portfolio of Oncotype tests include: Oncotype DX gene expression tests for breast, prostate and colon cancers; Oncotype DX AR-V7 Nucleus Detect® test, a liquid-based test for advanced stage prostate cancer; and Oncotype MAP™ Pan-Cancer Tissue test (oncomap test), a test delivering tumor profiling to aid therapy selection for patients with metastatic, refractory or recurrent cancer.
EXAS historical stock prices picture
EXACT Sciences (EXAS) has the following price history information. Looking back at EXAS historical stock prices for the last five trading days, on June 27, 2022, EXAS opened at $45.23, traded as high as $45.28 and as low as $42.52, and closed at $44.10. Trading volume was a total of 1.63M shares. On June 28, 2022, EXAS opened at $44.00, traded as high as $44.91 and as low as $40.95, and closed at $41.11. Trading volume was a total of 2.26M shares. On June 29, 2022, EXAS opened at $40.83, traded as high as $41.36 and as low as $39.61, and closed at $40.58. Trading volume was a total of 1.19M shares. On June 30, 2022, EXAS opened at $40.13, traded as high as $40.42 and as low as $38.53, and closed at $39.39. Trading volume was a total of 1.75M shares. On July 01, 2022, EXAS opened at $39.81, traded as high as $41.51 and as low as $39.61, and closed at $41.13. Trading volume was a total of 1.46M shares.

EXAS Historical Stock Prices By Date:

EXAS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into EXACT Sciences shares, starting with a $10,000 purchase of EXAS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/03/2012
End date: 07/01/2022
Start price/share: $11.18
End price/share: $41.13
Dividends collected/share: $0.00
Total return: 267.89%
Average Annual Total Return: 13.91%
Starting investment: $10,000.00
Ending investment: $36,780.58
Years: 10.00
Date Close
06/27/2022$44.10
06/28/2022$41.11
06/29/2022$40.58
06/30/2022$39.39
07/01/2022$41.13
EXAS is categorized under the Healthcare sector; below are some other companies in the same sector:

EXEL Historical Stock Prices
EYE Historical Stock Prices
EYEG Historical Stock Prices
EYES Historical Stock Prices
FATE Historical Stock Prices
FCRE Historical Stock Prices
FCSC Historical Stock Prices
FGEN Historical Stock Prices
FLDM Historical Stock Prices
FLGT Historical Stock Prices

Also explore: EXAS shares outstanding history

Email EnvelopeFree EXAS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

EXAS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.